1 study found for:    24095300 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Condition: Invasive Breast Cancer
Interventions: Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: trastuzumab;   Drug: lapatinib

Indicates status has not been verified in more than two years